Calumenin is a multiple EF-hand
INTRODUCTION
Calcium is an universal second messenger that plays important roles in various cellular processes such as gene expression, signal transduction, exocytosis and muscle contraction (1) . In striated muscle cells, muscle contraction and relaxation cycles are governed by Ca 2+ release and uptake occurring in the SR (2) . RyR and SERCA are the two main proteins in the SR responsible for Ca 2+ release and uptake, respectively. The SR contains also contains various resident proteins in the lumen that are involved in Ca 2+ buffering. Fluctuation in the luminal Ca 2+ concentration could modulate the quality and efficiency of protein folding and stability, as well as muscle contraction (3) . Calsequestrin (CSQ) (4), calreticulin (CRT) (5), sarcalumenin (6) , histidine-rich Ca
2+
-binding protein (HRC) (7) and calumenin (8, 9) have all been identified as important SR luminal proteins that could regulate Ca 2+ homeostasis in muscle cells. Among SR resident proteins, calumenin was recently characterized to be 315 aa in length and has a calculated molecular weight of 37 kDa (10, 11) . The N-terminal region of the calumenin protein contains a 19 aa signal sequence, whereas the C-terminal region has a unique 4 aa ER/SR retention signal (10) . Calumenin is ubiquitously expressed in different tissues with a higher expression level found in the heart (10) . Recent evidence suggests that calumenin is functionally associated with the release and uptake of Ca 2+ in the SR during the Ca 2+ cycling process (8, 9, 12 This review attempts to summarize the recent advances contributing to the overall knowledge of the biochemical and physiological properties of calumenin in striated muscle, especially focusing on biochemical and functional properties in mouse heart.
Genomic organization of calumenin
Mouse calumenin gene was first cloned and characterized from mouse heart using the signal sequence trap method (10) . Subsequent investigations have revealed that the calumenin gene has two alternatively spliced variants of equal length, named calumenin-1 and calumenin-2. Calumenin-2 was previously known as crotoxin-binding protein of 50 kDa (CBP50) or crocalbin (14, 15) . In comparing mouse calumenin-1 and -2, the 19 aa signal sequence and 4 aa ER/SR retention sequences are identical (16) . Calumenin protein contains one in vivo glycosylated N-glycosylation site at the 131st aa position. The aa sequences of mouse calumenin-1 and -2 have 92% identity and 95% homology (16) , with the difference lying in EF-hands-1 and -2. Despite this, the conserved amino acids closely resemble the consensus EF-hand sequence (17) .
Although the calumenin gene was initially mapped to the proximal portion of mouse chromosome 7, a recent investigation suggests its presence in chromosome 6 of the mouse genome (16) . Localization of calumenin to mouse chromosome 6 as well as that to human chromosome 7 are in conserved synteny with each other. Furthremore, the mouse cal-http://bmbreports.org BMB reports umenin gene contains six exons and five introns (16) . Exon 2 is different between calumenin-1 and -2; exon 2 of calumenin-2 is 72 bp before that of calumenin-1 in the 5' to 3' direction (16) .
Other CREC family members
Among other CREC family member proteins, the RCN1 gene encodes reticulocalbin protein (331 aa) containing a signal sequence, six EF-hands and the ER retention signal HDEL (18) . Although previously reported to be localized only to the ER, reticulocalbin has recently been found to be localized at the surface of bone endothelial cells and prostate cancer cells (19) . The translocation protein Sec63p located in the ER apparently interacts with reticulocalbin (20) . Similarly, the RCN2 gene encodes the ER Ca
2+
-binding protein 55 kDa (ERC-55), which is 317 aa long and contains a signal sequence, six EF-hands and the ER retention signal HDEL (21) . ERC-55 interacts with the human pappilomavirus (HPV)-encoded oncogenic protein E6, the vitamin D receptor (VDR), the neuronal pentraxins 1 (NP1) and 2 (NP2) and the snake venom taipoxin (22) . Another gene, RCN3, encodes a 328 aa precursor of reticulocalbin-3 containing a signal sequence, six EF-hands and the HDEL ER retention signal in its C-terminus. This protein interacts with proPACE4. The SDF4 gene encodes Cab45, a 362 aa protein containing a signal sequence, six EF-hands and the C-terminal ER retention signal HDEF (23, 24) . Cab45-C interacts with Munc18a and Munc 18b and is involved in the secretion process.
Calumenin polymorphisms
For the calumenin gene, at least 23 single nucleotide polymorphisms (one repeat or one insertion/deletion polymorphism) have been identified in the general population (25) . The effect of calumenin polymorphism on the anticoagulant response was also reported (26) . The polymorphism is localized to the 3'-untranslated region of the CALU gene.
Ca

2+ -binding properties of calumenin
Calumenin protein contains six EF-hands, each of which consists of typical helix-loop-helix motifs. The EF-hands undergo possible conformational changes upon Ca 2+ binding. Specifically, the binding of Ca 2+ to the individual EF-hands of calumenin was estimated to occur with a Kd of ~600 μM (11). To date, there is no clear structural explanation for the relatively low affinities of the EF-hands of calumenin when compared to the EF-hands found in other Ca 2+ -binding proteins (13).
Expression and localization of calumenin in striated muscle
Mouse and human calumenins are ubiquitously expressed in multiple tissues (10, 27) . Both calumenin isoforms in mouse are abundant in muscle, and transcription levels are higher in cardiac muscle than in skeletal muscle. The mRNA expression level of calumenin is decreased in the adult mouse heart compared to embryonic stages (10) . Likewise, calumenin protein expression during developmental stages was significantly decreased in adult mouse heart compared to embryonic and neonatal hearts (9) . The level of calumenin protein steadily decreased in mouse heart until reaching a steady state level that was maintained throughout adulthood. This indicates that the pattern of calumenin expression is similar to that of other ER chaperone proteins such as CRT, glucose regulated protein 78, glucose regulated protein 94, protein disulfide isomerase and ER protein 57 (ERp57) (28) Analysis of rabbit skeletal muscle showed that calumenin is abundant in the junctional fraction of rabbit skeletal SR where RyR1 is enriched, suggesting a possible interaction between calumenin and RyR1 (12). In ventricular myocytes and HL-1 cells, calumenin staining displayed clear localization along the Z-line and longitudinal axis of cardiomyocytes. This results suggest that calumenin is co-localized to areas of cardiomyocytes where SERCA2 and RyR2 are enriched (9) .
Calumenin in EC coupling
The muscle sarcotubular system, consisting of the SR and transverse tubules (TT), regulates Ca 2+ homeostasis within muscle cells and thereby muscle contraction and relaxation (2) . Muscle contraction and relaxation along with other physiological parameters are dependent on the composition of the components of the Ca 2+ handling apparatus. In skeletal muscle, the voltage sensor signal is transmitted to RyR via protein/protein interaction with the II-III loop of the dihydropyridine receptor (DHPR). In contrast, the coupling process in cardiac muscle depends on Ca 2+ entering the fiber through the DHPR channel and initiating Ca (Fig. 1) . In rat cardiomyocytes, calumenin over-expression was found to inhibit SERCA Ca 2+ uptake by direct interaction with SERCA2 (Fig. 1) .
On the other hand, calumenin knockdown by siRNA in myocytes does not affect SR Ca 2+ storage capacity (9) or total Ca2+ buffering capacity due to the fact that calumenin is a minor protein in the SR compared to CSQ (11, 29 
Characterization of calumenin interaction with SERCA and RyR in muscle cells
Calumenin can interact with various proteins in the SR. GSTull down and immunoprecipitation assays showed that the interaction between calumenin and SERCA is Ca 2+ dependent, and that the E1 state of SERCA shows higher association with calumenin than the E2 state (9) . A GST-pull down assay of different deleted regions of calumenin and SERCA2 showed that the SERCA-L4 region interacts with the calumenin middle region containing EF-hands 3 & 4. The SERCA-L4 region is the longest luminal loop in the SR and also interacts with ERp 57, which has been shown to regulate SERCA activity (31) . Molecular modeling has indicated that the association between calumenin and SERCA is dependent on 4 hydrophobic aa in the SERCA2-L4 region. This finding suggests that calumenin and SERCA interact by hydrophobic interaction. Similarly, calumenin interacts with RyR2 in mouse heart (9).
Functional role of calumenin in non-muscle cells
Calumenin interacts with a group of proteins in non-muscle cells. Serum amyloid P component (SAP) was the first protein reported to interact with calumenin in Ca 2+ -dependent fashion (32) . This interaction indicates that calumenin may participate in the immunological defense response and could be involved http://bmbreports.org BMB reports in amyloidosis that causes amyloid deposition in different types of tissues. Wallin et al. (33) have shown that calumenin is able to regulate γ-carboxylation in rat. The vitamin K-dependent γ-carboxylation system consisting of vitamin K1 2, 3 epoxide reductase (VKOR) and γ-glutamyl carboxylase is present in the ER (34) (35) (36) , and γ-carboxylation of proteins promotes complex formation with Ca
2+
. Over-expression of calumenin in COS-1 cells inhibits γ-carboxylase activity while the siRNA-mediated knockdown of calumenin increases γ-carboxylase activity (37), suggesting an inhibitory role for calumenin. Using immunoprecipitation experiments it was found that calumenin is directly associated with γ-carboxylase. Genetically engineered BHK21 cells over-expressing VKORC1 showed enhanced factor IX production upon calumenin gene silencing (38) . The above studies show that calumenin is an important regulator of the γ-carboxylation system, reinforcing the importance of the biosynthesis of functional vitamin K-dependent proteins.
Even though mouse calumenin is localized to the lumen of ER and is not secreted, Vorum et al. showed that calumenin is secreted from the ER in human cultured cells and localized to the secretory pathway (27) . This discrepancy is attributed to the inefficient ER retention signal HDEF. A recent finding shows that calumenin forms a Ca 2+ -dependent complex with thrombospondin-1 (TSP-1). Both calumenin and TSP-1 are released from thrombocytes upon stimulation with thrombin (39) . This suggests that calumenin may serve as a major factor in thrombosis.
Proteomic profiling of fibroblasts treated with calumenin shows that calumenin may modulate the cell cycle. This indicates a possible autocrine or paracrine effect for calumenin on nearby cells, which indicates possible involvement in the pathophysiology of thrombosis or wound healing (40) . Differential expression of calumenin is observed in cardiomyopathy, fracture healing and experimental nerve injury (41, 42) . Calumenin transcription was down-regulated in metastatic cells compared to primary tumor cells (43) . Calumenin was also down-regulated in hepatocellular carcinoma cells with high metastatic potentials compared to similar cells with low metastatic potentials (44) . Mass spectrometry analysis revealed that calumenin could be phosphorylated at Ser-44 and Thr-65 (45, 46) . A chemical genetic screening of v-src substrates identified calumenin as a tyrosine phosphorylation target, suggesting that calumenin is involved in signaling pathways (47) . Evidence also shows that calumenin is associated with the ER protein translocase, which leads to the translocation of calumenin from the cytosol to lumen (20) .
Summary
Calumenin is a CREC family Ca 2+ -binding protein that has diverse functions in different tissues. Evidence shows that abnormal expression of calumenin is associated with various pathological conditions such as cardiomyopathy. In striated muscle, calumenin interacts with RyR and SERCA in the SR and regulates the major pathways of Ca 2+ cycling involved in contractionrelaxation cycles. Based on the finding that expression of calumenin is gradually reduced from the embryonic stages to developmental stages, the functional role of calumenin could change dynamically during the development of striated muscle. Characterization of calumenin function in vivo is an interesting area for further investigation. http 
